Asia-Pacific Americas Africa Europe Middle East

PT EISAI INDONESIA

Company Profile:

Company Introduction

PT Eisai Indonesia is a subsidiary of Eisai Co., Ltd., a leading global research and development-based pharmaceutical company headquartered in Japan. The company is dedicated to the discovery, development, manufacturing, and marketing of innovative ethical pharmaceutical products. PT Eisai Indonesia aims to fulfill unmet medical needs and enhance patient well-being in Indonesia by focusing on various therapeutic areas, including neurology, oncology, and gastrointestinal disorders.

Business Type

PT Eisai Indonesia is primarily a factory (manufacturer). It operates manufacturing facilities in Indonesia for the production of pharmaceutical products, alongside its functions in marketing and distribution of these products nationwide.

Enterprise Products

PT Eisai Indonesia manufactures and/or markets the following products:

* Aricept (donepezil)

* Methycobal (mecobalamin)

* Lipitor (atorvastatin)

* Paracetamol

* Neurotropin

* Propanolol

* Eisai Skin Care Products

Business Registration Information:

Manager:

Isao Nakanishi
Phone:

+62 21 83701234
E-mail:

No Data
Official Website:
Address:

Gedung Menara Imperium Lantai 17, Jl. H.R. Rasuna Said Kav. 1, Kuningan, Jakarta Selatan 12980, Indonesia
This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.